Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-04

Clinical Trial Update: Amygdala Neurofeedback for Depression - Large Scale Clinical Trial [NA]

View source ↗

Summary

A large-scale clinical trial is recruiting to evaluate amygdala neurofeedback as a treatment for Major Depressive Disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Kymberly Young | Conditions: Major Depressive Disorder | NA | Status: RECRUITING